StockData
Vaxart, Inc. logo

Vaxart, Inc. (VXRT) stock

VXRTOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/30
$0.48+0.02 (+5.04%)

Close on Oct 19, 2026Market cap $115.15MP/E 3.2Yield –

Vaxart gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Vaxart's gross profit for the twelve months ending Jun 30, 2016 was -$25.20M, down 220.0% year over year. For fiscal 2015 it was $21.00M, up 19.3% from the year before. The highest annual figure on record is $21.00M in fiscal 2015.

Annual gross profit

PeriodPeriod endValueChange
FY2015Jun 30, 2015$21.00M+19.3%
FY2014Jun 30, 2014$17.60M+26.6%
FY2013Jun 30, 2013$13.90M+32.4%
FY2012Jun 30, 2012$10.50M+23.5%
FY2009Dec 26, 2009$8.50M–

Quarterly gross profit

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2016CQ2 2016Jun 30, 2016-$6.80M–
Q3 FY2016CQ1 2016Mar 31, 2016-$5.20M-572.7%
Q2 FY2016CQ4 2015Dec 31, 2015-$6.50M–
Q1 FY2016CQ3 2015Sep 30, 2015-$6.70M–
Q4 FY2015CQ2 2015Jun 30, 2015-$20.00M–
Q3 FY2015CQ1 2015Mar 31, 2015$1.10M–

More Vaxart figures

See a number that looks wrong?